Vyne Therapeutics Inc (VYNE NASDAQ) stock market data APIs
$30.1568
-2.25(-7.5%)
as of July 29, 2026
Try our APIs with
free plan!
Vyne Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a topically administered small molecule pan-bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple and diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor in Phase 1b trial for the acute control and chronic management of immune-mediated inflammatory conditions. VYNE Therapeutics Inc. was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. The company was founded in 2003 and is based in Stewartsville, New Jersey.
Prev. Close
30.1568
Open
27.9058
High
32.0861
Low
27.8085
52 wk Range
0.0021-46.95
Market Cap
19 070 K
Shares Outstanding
668 K
Revenue
454 K
EPS
-0.0838
Dividends (Yield)
0
Beta
2.006
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Vyne Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vyne Therapeutics Inc data using free add-ons & libraries
Get Vyne Therapeutics Inc Fundamental Data
Vyne Therapeutics Inc Fundamental data includes:
- Net Revenue: 454 K
- EBITDA: -24 345 000
- Earnings Per Share: -27
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-18
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vyne Therapeutics Inc News
New
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience
VYNE Therapeutics Inc. NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its previously announced special cash dividen...
VYNE Therapeutics Approves 1-for-50 Reverse Stock Split Ahead Of Merger With Yarrow Bioscience
(RTTNews) - VYNE Therapeutics Inc. (VYNE) announced that its Board of Directors has approved a 1-for-50 reverse stock split of its common stock in connection with the anticipated closing of its merger...
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
VYNE Therapeutics Inc. Aggregate cash dividend of $17.3 million, or approximately $0.40242 per share NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the ...
VYNE Therapeutics declares $0.38/share merger-contingent special dividend
* VYNE Therapeutics (VYNE [https://seekingalpha.com/symbol/VYNE]) declares $0.38/share special dividend [https://seekingalpha.com/pr/20579147-vyne-therapeutics-declares-special-cash-dividend-in-conn...
Get Vyne Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
